CG Oncology (CGON) News Today $20.11 +0.05 (+0.25%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$20.10 -0.02 (-0.07%) As of 04/15/2025 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period CG Oncology (CGON) vs. Its Peers Head-To-Head ContrastApril 12, 2025 | americanbankingnews.comCenterBook Partners LP Sells 73,188 Shares of CG Oncology, Inc. (NASDAQ:CGON)CenterBook Partners LP cut its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 23.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 236,108 shares of the company's stock after selling 73,188 shares during tApril 11, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Receives Average Rating of "Buy" from AnalystsCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has received a consensus rating of "Buy" from the ten research firms that are presently covering the firm, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recomApril 10, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Sets New 52-Week Low - What's Next?CG Oncology (NASDAQ:CGON) Hits New 1-Year Low - Time to Sell?April 9, 2025 | marketbeat.comADAR1 Capital Management LLC Buys 72,646 Shares of CG Oncology, Inc. (NASDAQ:CGON)ADAR1 Capital Management LLC increased its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 50.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 215,750 shares of the company's stock after acquiring an additionaApril 9, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Sells 22,788 Shares of CG Oncology, Inc. (NASDAQ:CGON)Massachusetts Financial Services Co. MA lowered its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 8.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 257,157 shares of the company's stock after selling 22,788 shaApril 9, 2025 | marketbeat.comBuy Rating Affirmed for CG Oncology Amid Promising Trial Data and Market OpportunitiesApril 8, 2025 | tipranks.comVanguard Group Inc. Has $168.10 Million Stock Position in CG Oncology, Inc. (NASDAQ:CGON)Vanguard Group Inc. raised its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 15.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,861,082 shares of the company's stock after purchasing an additional 779,7April 8, 2025 | marketbeat.comAlliancebernstein L.P. Purchases 692,982 Shares of CG Oncology, Inc. (NASDAQ:CGON)Alliancebernstein L.P. raised its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 61.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,817,887 shares of the company's stock after buying an additional 692,982 shares during tApril 7, 2025 | marketbeat.comFranklin Resources Inc. Buys 45,698 Shares of CG Oncology, Inc. (NASDAQ:CGON)Franklin Resources Inc. boosted its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 3.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,275,891 shares of the company's stock after purchasing an additional 4April 7, 2025 | marketbeat.comWellington Management Group LLP Purchases 1,400,251 Shares of CG Oncology, Inc. (NASDAQ:CGON)Wellington Management Group LLP lifted its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 274.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,910,470 shares of the company's stocApril 7, 2025 | marketbeat.comCG Oncology (CGON) vs. Its Competitors Financial AnalysisApril 7, 2025 | americanbankingnews.comPamalican Asset Management Ltd Invests $5.21 Million in CG Oncology, Inc. (NASDAQ:CGON)Pamalican Asset Management Ltd bought a new stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 181,582 shares of the company's stock, valued at approximately $5,2April 6, 2025 | marketbeat.comCinctive Capital Management LP Makes New $648,000 Investment in CG Oncology, Inc. (NASDAQ:CGON)Cinctive Capital Management LP acquired a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,608 shares of the company's stock, valApril 6, 2025 | marketbeat.comHC Wainwright Has Negative View of CG Oncology Q1 EarningsCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities researchers at HC Wainwright lowered their Q1 2025 EPS estimates for CG Oncology in a research note issued to investors on Monday, March 31st. HC Wainwright analyst A. Maldonado now expects that the company will earn ($0.58) per share for tApril 5, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Reaches New 12-Month Low - What's Next?CG Oncology (NASDAQ:CGON) Reaches New 1-Year Low - Here's What HappenedApril 3, 2025 | marketbeat.comBrokers Offer Predictions for CG Oncology FY2029 EarningsCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities research analysts at HC Wainwright issued their FY2029 EPS estimates for shares of CG Oncology in a note issued to investors on Monday, March 31st. HC Wainwright analyst A. Maldonado forecasts that the company will post earnings of $1.34 peApril 3, 2025 | marketbeat.comCantor Fitzgerald Lowers Earnings Estimates for CG OncologyCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of CG Oncology in a research report issued to clients and investors on Monday, March 31st. Cantor Fitzgerald analyst J. Schimmer now anticipatesApril 3, 2025 | marketbeat.comTeacher Retirement System of Texas Acquires Shares of 11,927 CG Oncology, Inc. (NASDAQ:CGON)Teacher Retirement System of Texas bought a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 11,927 shares of the company's stock, valued at approximately $342,000. Several otheApril 3, 2025 | marketbeat.comCG Oncology Looks Attractive At Current Prices (Rating Upgrade)April 2, 2025 | seekingalpha.comPictet Asset Management Holding SA Buys New Stake in CG Oncology, Inc. (NASDAQ:CGON)Pictet Asset Management Holding SA purchased a new position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 674,607 shares of the company's stock, valued at appApril 2, 2025 | marketbeat.comCorebridge Financial Inc. Has $2.67 Million Holdings in CG Oncology, Inc. (NASDAQ:CGON)Corebridge Financial Inc. decreased its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 31.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 93,189 shares of the company's stock after selling 4April 2, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Trading Down 8.1% - Should You Sell?CG Oncology (NASDAQ:CGON) Stock Price Down 8.1% - What's Next?April 1, 2025 | marketbeat.comCG Oncology's (CGON) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $75.00 target price on shares of CG Oncology in a research note on Monday.April 1, 2025 | marketbeat.comCG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and UpdatesApril 1, 2025 | markets.businessinsider.comAnalysts Offer Insights on NA Companies: Nano Nuclear Energy Inc. (NNE) and CG Oncology, Inc. (CGON)March 31, 2025 | markets.businessinsider.comCG Oncology, Inc. (CGON) Gets a Buy from Morgan StanleyMarch 31, 2025 | markets.businessinsider.comBuy Rating for CG Oncology, Inc. Driven by Promising Developments in Bladder Cancer TreatmentMarch 31, 2025 | tipranks.comCG Oncology reports FY24 EPS ($1.41) vs ($15.65) last yearMarch 29, 2025 | markets.businessinsider.comCG Oncology files automatic mixed securities shelfMarch 29, 2025 | markets.businessinsider.comCG Oncology Advances in Bladder Cancer TherapeuticsMarch 29, 2025 | tipranks.comCG Oncology announces mixed shelf offeringMarch 28, 2025 | msn.comCG Oncology Reports 2024 Year End Financial Results and Provides Business UpdatesMarch 28, 2025 | markets.businessinsider.comCG Oncology, Inc. GAAP EPS of -$0.46March 28, 2025 | seekingalpha.comSwiss National Bank Has $2.28 Million Position in CG Oncology, Inc. (NASDAQ:CGON)Swiss National Bank lifted its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 144.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 79,600 shares of the company's stock after buying an additional 47,000 shares during the perioMarch 28, 2025 | marketbeat.comExpert Outlook: CG Oncology Through The Eyes Of 4 AnalystsMarch 27, 2025 | nasdaq.comCG Oncology's (CGON) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $75.00 price objective on shares of CG Oncology in a report on Tuesday.March 26, 2025 | marketbeat.comFirst Week of CGON May 16th Options TradingMarch 26, 2025 | nasdaq.comCG Oncology says 75.5% of patients achieve CR in Phase 3 study of cretostimogeneMarch 26, 2025 | markets.businessinsider.com4CGON : Expert Outlook: CG Oncology Through The Eyes Of 4 AnalystsMarch 25, 2025 | benzinga.comIntech Investment Management LLC Acquires New Shares in CG Oncology, Inc. (NASDAQ:CGON)Intech Investment Management LLC acquired a new position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 16,787 shares of the company's stock, valMarch 25, 2025 | marketbeat.comCG Oncology’s Promising Phase 3 Trial Results RevealedMarch 24, 2025 | tipranks.comCretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and EfficacyMarch 24, 2025 | globenewswire.comiA Global Asset Management Inc. Takes Position in CG Oncology, Inc. (NASDAQ:CGON)iA Global Asset Management Inc. bought a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 45,890 shares of the company's stock, valued at approximaMarch 23, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Shares Bought by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 12.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 427,760 shares of the company's stock after buying an additional 48,096 shares during theMarch 22, 2025 | marketbeat.comBank of New York Mellon Corp Decreases Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON)Bank of New York Mellon Corp decreased its holdings in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 135,567 shares ofMarch 19, 2025 | marketbeat.comCG Oncology (CGON) Expected to Announce Quarterly Earnings on TuesdayCG Oncology (NASDAQ:CGON) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.com11,853 Shares in CG Oncology, Inc. (NASDAQ:CGON) Purchased by Arizona State Retirement SystemArizona State Retirement System purchased a new stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 11,853 shares of the company's stock, valued at approximately $340,000. Other hedge fMarch 16, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Up 7.3% - What's Next?CG Oncology (NASDAQ:CGON) Stock Price Up 7.3% - Still a Buy?March 15, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Receives Average Recommendation of "Buy" from BrokeragesCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has been given an average recommendation of "Buy" by the ten research firms that are currently covering the firm, MarketBeat.com reports. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company.March 15, 2025 | marketbeat.com Remove Ads Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address CGON Media Mentions By Week CGON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGON News Sentiment▼1.160.79▲Average Medical News Sentiment CGON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGON Articles This Week▼74▲CGON Articles Average Week Remove Ads Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Blueprint Medicines News Today Sarepta Therapeutics News Today Telix Pharmaceuticals Limited American Depositary Shares News Today Axsome Therapeutics News Today Krystal Biotech News Today Nuvalent News Today Grifols News Today Elanco Animal Health News Today Verona Pharma News Today ADMA Biologics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGON) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
